These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 24120854)

  • 21. Development of a novel cyclic RGD peptide for multiple targeting approaches of liposomes to tumor region.
    Amin M; Mansourian M; Koning GA; Badiee A; Jaafari MR; Ten Hagen TLM
    J Control Release; 2015 Dec; 220(Pt A):308-315. PubMed ID: 26526970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sequential treatment of drug-resistant tumors with RGD-modified liposomes containing siRNA or doxorubicin.
    Jiang J; Yang SJ; Wang JC; Yang LJ; Xu ZZ; Yang T; Liu XY; Zhang Q
    Eur J Pharm Biopharm; 2010 Oct; 76(2):170-8. PubMed ID: 20600887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab.
    Höbel S; Koburger I; John M; Czubayko F; Hadwiger P; Vornlocher HP; Aigner A
    J Gene Med; 2010 Mar; 12(3):287-300. PubMed ID: 20052738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
    Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
    Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A pH-sensitive fusogenic peptide facilitates endosomal escape and greatly enhances the gene silencing of siRNA-containing nanoparticles in vitro and in vivo.
    Hatakeyama H; Ito E; Akita H; Oishi M; Nagasaki Y; Futaki S; Harashima H
    J Control Release; 2009 Oct; 139(2):127-32. PubMed ID: 19540888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Temperature-triggered tumor-specific delivery of anticancer agents by cRGD-conjugated thermosensitive liposomes.
    Kim MS; Lee DW; Park K; Park SJ; Choi EJ; Park ES; Kim HR
    Colloids Surf B Biointerfaces; 2014 Apr; 116():17-25. PubMed ID: 24441178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct cytosolic siRNA delivery by reconstituted high density lipoprotein for target-specific therapy of tumor angiogenesis.
    Ding Y; Wang Y; Zhou J; Gu X; Wang W; Liu C; Bao X; Wang C; Li Y; Zhang Q
    Biomaterials; 2014 Aug; 35(25):7214-27. PubMed ID: 24875759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Multifunctional Envelope-Type Nano Device Containing a pH-Sensitive Cationic Lipid for Efficient Delivery of Short Interfering RNA to Hepatocytes In Vivo.
    Sato Y; Harashima H; Kohara M
    Methods Mol Biol; 2016; 1364():71-8. PubMed ID: 26472443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modality of tumor endothelial VEGFR2 silencing-mediated improvement in intratumoral distribution of lipid nanoparticles.
    Yamamoto S; Kato A; Sakurai Y; Hada T; Harashima H
    J Control Release; 2017 Apr; 251():1-10. PubMed ID: 28192155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RGD-based active targeting of novel polycation liposomes bearing siRNA for cancer treatment.
    Yonenaga N; Kenjo E; Asai T; Tsuruta A; Shimizu K; Dewa T; Nango M; Oku N
    J Control Release; 2012 Jun; 160(2):177-81. PubMed ID: 22019557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antineovascular gene therapy by Ago2 knockdown].
    Hatanaka K; Shimizu K; Asai T; Oku N
    Yakugaku Zasshi; 2008 Nov; 128(11):1567-75. PubMed ID: 18981691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor-targeting dual peptides-modified cationic liposomes for delivery of siRNA and docetaxel to gliomas.
    Yang ZZ; Li JQ; Wang ZZ; Dong DW; Qi XR
    Biomaterials; 2014 Jun; 35(19):5226-39. PubMed ID: 24695093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Size-dependent specific targeting and efficient gene silencing in peritoneal macrophages using a pH-sensitive cationic liposomal siRNA carrier.
    Matsui H; Sato Y; Hatakeyama H; Akita H; Harashima H
    Int J Pharm; 2015 Nov; 495(1):171-178. PubMed ID: 26355712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery.
    Landen CN; Chavez-Reyes A; Bucana C; Schmandt R; Deavers MT; Lopez-Berestein G; Sood AK
    Cancer Res; 2005 Aug; 65(15):6910-8. PubMed ID: 16061675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lentivirus-mediated shRNA interference targeting vascular endothelial growth factor inhibits angiogenesis and progression of human pancreatic carcinoma.
    Zhao X; Zhu DM; Gan WJ; Li Z; Zhang JL; Zhao H; Zhou J; Li DC
    Oncol Rep; 2013 Mar; 29(3):1019-26. PubMed ID: 23254994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional improvement of an IRQ-PEG-MEND for delivering genes to the lung.
    Ishitsuka T; Akita H; Harashima H
    J Control Release; 2011 Aug; 154(1):77-83. PubMed ID: 21619903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanoparticles for ex vivo siRNA delivery to dendritic cells for cancer vaccines: programmed endosomal escape and dissociation.
    Akita H; Kogure K; Moriguchi R; Nakamura Y; Higashi T; Nakamura T; Serada S; Fujimoto M; Naka T; Futaki S; Harashima H
    J Control Release; 2010 May; 143(3):311-7. PubMed ID: 20080139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PEI-g-PEG-RGD/small interference RNA polyplex-mediated silencing of vascular endothelial growth factor receptor and its potential as an anti-angiogenic tumor therapeutic strategy.
    Kim J; Kim SW; Kim WJ
    Oligonucleotides; 2011; 21(2):101-7. PubMed ID: 21375397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atu027, a liposomal small interfering RNA formulation targeting protein kinase N3, inhibits cancer progression.
    Aleku M; Schulz P; Keil O; Santel A; Schaeper U; Dieckhoff B; Janke O; Endruschat J; Durieux B; Röder N; Löffler K; Lange C; Fechtner M; Möpert K; Fisch G; Dames S; Arnold W; Jochims K; Giese K; Wiedenmann B; Scholz A; Kaufmann J
    Cancer Res; 2008 Dec; 68(23):9788-98. PubMed ID: 19047158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Small interference RNAs directed against KDR gene inhibit the proliferation of breast cancer cells in vitro and in vivo].
    Zhang XJ; Ge YL; Hou L; Li Q
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Jan; 24(1):58-61. PubMed ID: 18177622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.